Abstract
Alzheimer disease (AD) is the most common type of dementia and one of the most serious mental health problems. Based on data analysis for classification of dementia, it is possible to distinguish the subjects into three groups: cognitively normal (CN), mild cognitive impairment (MCI) and AD. In this paper, the information of 628 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.) database was used which contains 2163 features in order to select the most significant features that allows to the classification of CN vs. MCI/AD, the genetic package GALGO was applied to the features in which four features were selected and four classification techniques were used: Logistic Regression (LR), Random Forest (RF), Artificial Neural Networks (ANN) and Support Vector Machines (SVM). A cross validation of 70% training 30% test. According to the results, the technique with the most significant area under the curve (AUC) for the classification the subjects was LR presenting a value of 0.842.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prince, M., et al.: World Alzheimer report 2015 the global impact of dementia an analysis of prevalence, incidence, cost and trends. Technical report, Alzeimer’s Disease International, United Kindom (2015). www.alz.co.uk/worldreport2015corrections
Patterson, C.: World Alzheimer report 2018 - the state of the art of dementia research: new frontiers; World Alzheimer report 2018 - the state of the art of dementia research: New frontiers. Technical report, pp. 1–8. Alzheimer’s Disease International (ADI), London (2018). https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf
Casanova, R., et al.: Alzheimer’s disease risk assessment using large- scale machine learning methods. PLoS One 8(11), e77949 (2013). https://doi.org/10.1371/journal.pone.0077949. Ed. by Stephen D Ginsberg
Hinrichs, C., et al.: Predictive markers for AD in a multi-modality frame- work: an analysis of MCI progression in the ADNI population. Neuroimage 55, 574–589 (2011)
Jo, T., Nho, K., Saykin, A.J.: Deep learning in Alzheimer’s disease: diagnostic classification and prognostic prediction using neuroimaging data. arXiv e-prints, May 2019. http://arxiv.org/abs/1905.00931
R Core Team: The R Project for Statistical Computing (2019). https://www.r-project.org/
Trevino, V., Falciani, F.: GALGO An R package for genetic algorithm searches (customized for variable selection in functional genomics). Technical report (2005). http://www.wag-inc.org
Liaw, A., Wiener, M.: Classification and Regression by randomForest. Technical repot, vol. 3, pp. 18–22 (2002). https://www.r-project.org/doc/Rnews/Rnews2002-3.pdf
Meyer, D.: Support vector machines * the interface to LIBSVM in pack- age e1071. Technical report, pp. 1–8. FH Technikum, Wien (2019). http://www.csie.ntu.edu.tw/~cjlin/papers/ijcnn.ps.gz
Robin, X., et al.: pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12(1), 77 (2011). https://doi.org/10.1186/1471-2105-12-77. https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-12-77
ADNI - Alzheimer’s Disease Neuroimaging Initiative (2003). http://adni.loni.usc.edu/
Honea, R.A., et al.: Impact of APOE on the healthy aging brain: a voxel- based MRI and DTI study. J. Alzheimers Dis. 18, 553–564 (2009)
Acknowledgments
Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Author information
Authors and Affiliations
Consortia
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Sánchez-Reyna, A.G. et al. (2020). Feature Selection and Machine Learning Applied for Alzheimer’s Disease Classification. In: González Díaz, C., et al. VIII Latin American Conference on Biomedical Engineering and XLII National Conference on Biomedical Engineering. CLAIB 2019. IFMBE Proceedings, vol 75. Springer, Cham. https://doi.org/10.1007/978-3-030-30648-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-30648-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30647-2
Online ISBN: 978-3-030-30648-9
eBook Packages: EngineeringEngineering (R0)